Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01648543
Other study ID # 3-2012-0042
Secondary ID
Status Recruiting
Phase N/A
First received July 19, 2012
Last updated July 23, 2012
Start date June 2012
Est. completion date December 2012

Study information

Verified date July 2012
Source Yonsei University
Contact Jong Bum Choi
Phone +82-2-2019-6093
Email ROMEOJB@yuhs.ac
Is FDA regulated No
Health authority Korea: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

Lumbar sympathetic ganglion block is used for several neuropathic pain syndromes. The best method of lumbar sympathetic ganglion block is not established. The investigators would compare two methods of lumbar sympathetic ganglion block. One is modified Reid method which's entry point is 7~7.5cm from midline of spinous process of lumbar spine. The other is angular method which's entry angle is 30 degree from anterior-posterior view of C-arm. Comparison modified Reid method with angular method would be helpful for finding best method of lumbar sympathetic ganglion block.


Recruitment information / eligibility

Status Recruiting
Enrollment 194
Est. completion date December 2012
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender Both
Age group 20 Years and older
Eligibility Inclusion Criteria:

1. Adults above age of 20

2. Undergoing lumbar sympathetic ganglion block indication

Exclusion Criteria:

1. Infection

2. Bleeding tendency

3. Previous spinal surgery history

4. Pregnancy

5. Illiteracy

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Hyperhidrosis
  • Lumbar Sympathetic Ganglion Block Indication: Neuropathic Pain, CRPS, Hyperhydrosis Etc.
  • Neuralgia

Intervention

Procedure:
lumbar sympathetic ganglion block


Locations

Country Name City State
Korea, Republic of Gangnam Severance Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary temperature change 30min No
Primary muscle or vessel shadow 30min No